Incidence and Distribution of Lobe-Specific Mediastinal Lymph Node Metastasis in Non-small Cell Lung Cancer: Data from 4511 Resected Cases
- 6 August 2018
- journal article
- research article
- Published by Springer Science and Business Media LLC in Annals of Surgical Oncology
- Vol. 25 (11), 3300-3307
- https://doi.org/10.1245/s10434-018-6394-9
Abstract
Objective We aimed to investigate the incidence and distribution of mediastinal lymph node metastases (MLNM) in operable non-small cell lung cancer (NSCLC) with the purpose of guiding mediastinal lymph node dissection (MLND). Methods A total of 4511 NSCLC patients who underwent resection between January 2001 and December 2014 were included. These patients were preoperatively untreated and grouped according to the primary tumor lobes. The incidence and distribution of pathologic MLNM were compared among groups, and multivariate analysis was conducted to find the independent factors impacting MLNM. Results Lymph node involvement was observed in 1784 patients (39.5%). A total of 628 cases (13.9%) were N1-positive only, 752 cases (16.7%) were both N1- and N2-positive, and 404 cases (9.0%) were N2-positive only. The most common sites of mediastinal metastasis for different primary tumor lobes were the right upper lobe, station 4R (21.5%, 192/893); right middle lobe, station 7 (21.1%, 69/327); right lower lobe, station 7 (24.1%, 212/878); left upper lobe, station 5 (22.2%, 224/1008); and left lower lobe, station 7 (21.7%, 136/628). However, when only N2 cases were considered, each mediastinal lymph node zone can be involved with metastasis to a high proportion (> 5%). Multivariable analyses showed that poor cell differentiation, adenocarcinoma, larger tumor size, central type, and younger age were independent factors favoring MLNM. Conclusions Different primary tumor locations have a different propensity to be sites of MLNM; however, once MLNM occurs, each zone can be involved and should not be neglected. Systematic MLND is the preferred procedure for operable NSCLC.Keywords
Funding Information
- the Natural Science Foundation of Guangdong Province (2016A030313857)
- the science and technology planning project of Guangdong province (2013B021800147)
- The National Natural Science Foundation of China (81501986)
- The Guangdong Provincial Medical Scientific Funds (2016114134515565)
This publication has 28 references indexed in Scilit:
- Retrospective Analysis of Nodal Spread Patterns According to Tumor Location in Pathological N2 Non‐small Cell Lung CancerWorld Journal of Surgery, 2012
- Nodal involvement pattern in resectable lung cancer according to tumor locationCancer Management and Research, 2012
- Complete mediastinal lymphadenectomy: the core component of the multidisciplinary therapy in resectable non-small cell lung cancerEuropean Journal of Cardio-Thoracic Surgery, 2008
- Skip Mediastinal Nodal Metastases in the IIIa/N2 Non-Small Cell Lung CancerJournal of Thoracic Oncology, 2007
- Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small Cell Lung CancerThe Annals of Thoracic Surgery, 2005
- The new strategy of selective nodal dissection for lung cancer based on segment-specific patterns of nodal spreadInteractive CardioVascular and Thoracic Surgery, 2005
- Involvement of lymphatic metastatic spread in non-small cell lung cancer accordingly to the primary cancer locationLung Cancer, 2004
- Skip metastases: analysis of their clinical significance and prognosis in the IIIA stage of non-small cell lung cancerEuropean Journal of Cardio-Thoracic Surgery, 2004
- Role of skip metastasis to mediastinal lymph nodes in non‐small cell lung cancerJournal of Surgical Oncology, 2003
- Extent of mediastinal node metastasis in clinical stage I non-small-cell lung cancer: The role of systematic nodal dissectionLung Cancer, 1998